Xylitol, a sugar substitute found in chewing gum, baked goods and toothpaste, was associated with long-term cardiovascular risks in a new study of more than 17,000 adults.

Johnson & Johnson is selling key assets related to its Laminar program to a new startup, Jaguar LAA. This comes less than three years after Johnson & Johnson acquired Laminar for $400 million. 

The AHA has developed systems of care that can help developing countries improve their treatment strategies for both heart attack and stroke.

Stroke patients should begin their road to recovery as soon as they are medically stable, according to a new ASA/AHA guideline. In fact, starting within the first 48 hours is recommended to maximize the patient’s chance of a full recovery.

XCath Robotics has received the FDA's breakthrough device designation for its Iris surgical robotic system. The device is used to perform remote robotic-assisted mechanical thrombectomy on patients with acute ischemic stroke.

AI technology developed by Caristo Diagnostics was the focus of multiple studies presented at ESC Congress 2026.

Researchers tracked data from more than 480,000 U.K. Biobank participants, using cardiac MRI scans to identify signs of inflammation. 

The Emboliner Embolic Protection System held its own in a recent head-to-head comparison with Boston Scientific’s Sentinel Cerebral Protection System. With FDA approval now secured, Emboline hopes to launch the device in the months ahead. 

In addition, higher doses of oral HRT may slightly increase a woman's risk of experiencing a heart attack or stroke.